New Medicated Whitening*¹ Serum 'TAKAMI BRIGHT SPOT B3+' Wins 3 Best Cosmetics Awards*²!

TAKAMI (Headquarters: Shinjuku-ku, Tokyo; www.takami-labo.com), a skincare brand born from the experience of treating the skin of over 200,000*³ people at their aesthetic dermatology clinic in Omotesando, Tokyo, is proud to announce that its new medicated whitening*¹ serum, 'TAKAMI BRIGHT SPOT B3+', has won three 'Best Cosmetics' awards*² within just one month of its release. ■ Adult whitening*¹ care that won 3 Best Cosmetics whitening category awards*² in just one month. Prevents dark spots*⁴, improves wrinkles, and prevents acne with a single bottle. Released in February 2026, 'TAKAMI BRIGHT SPOT B3+' is TAKAMI's first medicated whitening*¹ serum, developed by focusing on the complex process of dark spot formation. Featuring a 'Melanin Tracking Approach*⁵,' it targets*⁶ concerns directly, much like a laser. The proprietary 'Laser Complex*⁷' formula balances whitening*¹ care with exfoliation. As a quasi-drug, it not only prevents dark spots*⁴ but also improves wrinkles and prevents acne while providing high moisturizing effects. With a focus on a deeply hydrated finish felt from within, this adult whitening*¹ care has secured three 'Best Cosmetics' awards*² in the whitening category within just one month of launch. ・MAQUIA Brightening & UV Grand Prix 2026: 1st Place, Sensitive Skin Category ・美ST (BiST) April 2026 Issue: 2nd Place, Whitening Best Cosmetics, 'Fluctuation Whitening' Award ・美ST (BiST) April 2026 Issue: 3rd Place, Whitening Best Cosmetics, 'Whitening + Pore' Award ▼ Click here for TAKAMI BRIGHT SPOT B3+: https://www.takami-labo.com/special/essence_b3/